By Alberto Arnedillo
Introduction: A Biological Clock I Refuse to Ignore
At 60, the word *longevity* takes on visceral meaning. It’s not just about living longer but living well—with autonomy and without the shadow of preventable disease. For me, that shadow takes the shape of a prostate gland: a small but critical organ tied to a family history marked by cancer. My paternal grandfather died from metastatic prostate cancer, and my father battled it. So, when my PSA levels began climbing alarmingly, I became my own case study. This article is not just my story; it’s a scientific exploration, a call to action, and a reflection on how personalized medicine and prevention could redefine our approach to aging.
Chapter 1: PSA and the Inheritance I Didn’t Choose
Prostate-specific antigen (PSA) is a protein produced by the prostate. Elevated levels can signal inflammation, benign enlargement (BPH), or cancer. For years, my PSA hovered below 2 ng/mL. But in 2021, it began rising: 1.8, 2.1, 2.5 by December 2023. The doubling of my PSA in two years triggered alarms. According to Harvard’s prostate cancer risk formula, a velocity >0.75 ng/mL per year significantly raises malignancy risk.
Genetic baggage:
– My grandfather died at 68 from metastatic prostate cancer.
– My father was diagnosed at 72 but survived with early treatment.
– A 2020 *JAMA Oncology* study found that having a first-degree relative with prostate cancer triples one’s risk.
Yet there was a paradox: While my prostate had **tripled in size** (confirmed via ultrasound), I lacked classic urinary symptoms. Was this benign hyperplasia? Or something more sinister?
Chapter 2: Hunting Answers in the Scientific Literature
I refused to wait passively for my urology appointment. Diving into PubMed and journals, I uncovered two compelling findings:
1. Vitamin D: A PSA Brake
– A 2017 meta-analysis in *Cancer Epidemiology, Biomarkers & Prevention* linked low vitamin D levels to elevated PSA in African American men.
– A 2019 *Clinical Cancer Research* study suggested vitamin D inhibits prostate cancer cell proliferation *in vitro*.
My protocol:
– Daily **4,000 IU vitamin D3** + **100 mcg vitamin K2** (to prevent arterial calcification, per the *Journal of Nutrition*).
2. Statins: A Serendipitous Side Effect?
– A 2021 *Prostate Cancer and Prostatic Diseases* study showed statins reduce PSA in men with hyperlipidemia.
– The theory: Statins lower systemic inflammation and may modulate 5-alpha-reductase activity (an enzyme linked to prostate growth).
My experience:
– After 6 months of **atorvastatin 20 mg/day**, my PSA dropped to **1.8 ng/mL** (a 28% decrease!).
Chapter 3: The Speedometer Dilemma: Gaming the System or Understanding It?
This raises a critical question: **Does lowering PSA equate to lowering cancer risk?**
Using your analogy: Imagine driving 200 km/h but tampering with the speedometer to read 90. The danger remains, even if the gauge lies. PSA works similarly—it’s a *marker*, not a *causal biomarker*.
The science’s limits:
– Some prostate cancers are “silent” and don’t elevate PSA (*New England Journal of Medicine*, 2023).
– BPH and infections also skew PSA, creating false alarms.
My preliminary conclusion:
My PSA drop might reflect reduced prostate inflammation (a tangible benefit), but it doesn’t rule out malignancy.
Chapter 4: The Experiment Continues: Quitting Statins
In March 2024, I stopped statins to test their impact. Three months later, my PSA rose to **1.97 ng/mL**. Coincidence or causation?
Key data:
– Statins lower LDL cholesterol but also have pleiotropic effects (anti-inflammatory, antioxidant).
– A 2022 *European Urology* trial linked long-term statin use to a **20% lower risk of aggressive prostate cancer**.
My takeaway:
Was stopping them worth the risk? Likely not. I’ll resume statins after consulting my urologist.
Chapter 5: Lessons for Longevity
1. Supplements Aren’t Magic
Vitamin D is safe in moderate doses (toxicity begins at >10,000 IU/day, per *Mayo Clinic*), but its role in prostate health remains unclear.
2. Genetics Aren’t Destiny
Yes, my risk is elevated, but lifestyle matters. I adopted:
– A Mediterranean diet (tomatoes rich in lycopene, nuts, fatty fish).
– Daily exercise (sedentary habits raise PSA, per *Cancer Causes & Control*).
3. Active Surveillance as a Tool
My next step: **MRI-guided multiparametric biopsy**, the gold standard for detecting occult cancers (*The Lancet*, 2023).
Epilogue: Toward Proactive Medicine
This journey taught me that longevity isn’t a number on a lab report but a balance of science, caution, and informed action. Yes, I lowered my PSA, but that doesn’t make me invincible. The prostate remains a treacherous organ, and cancer, a stealthy foe.
My message to you:
– **Research rigorously.** Not every PubMed study applies to your case.
– **Collaborate with doctors.** My experiment was supervised by an endocrinologist.
– **Don’t fear markers.** PSA is imperfect, but it’s the best we have… for now.
And yes, I’ll keep reporting. Because every data point, every fluctuation, is a step toward the goal we all share: living not just more years, but more *life* in every year.
—
**Author’s Note:** This article is not medical advice. Consult your specialist before altering treatments.